Blog Read the latest perspectives from our team of subject matter experts and others Drug Development Predictions 2026The drug development landscape is undergoing rapid transformation. After a year of significant policy changes, regulatory updates, and technology maturation, 2026 will be a defining year for how clinical… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Artificial IntelligenceDrug DevelopmentDrug Development Predictions 2026The drug development landscape is undergoing rapid transformation. After a year of significant policy changes, regulatory updates, and technology maturation, 2026 will be a defining year for how clinical… Continue reading → Read the articleyes Artificial IntelligenceProvider DataHealthcare Predictions 2026: Market Shifts That Will Define the IndustryFor 2026, we predict four significant developments in healthcare: provider data regulations will require new compliance standards, health plans will make consumer experience a top strategic priority to win new… Continue reading → Read the articleyes Drug DevelopmentUnlocking Smarter Clinical Trial Feasibility with Connected DataWhen it comes to clinical trial feasibility, the stakes are high. Choosing the wrong sites or drafting a protocol without full visibility into patient populations can lead to costly… Continue reading → Read the articleno KOL EngagementFrom Fragmented to Connected: Unlocking the Power of 360° HCP EngagementAt Fierce Pharma Week 2025, Stacey Rivkin took the stage to address one of pharma’s most persistent challenges: despite having more data than ever before, medical and commercial teams still… Continue reading → Read the articleno KOL EngagementHow H1 Integrates with Your CRM of ChoiceAt H1, we know that every life sciences organization has unique needs when it comes to customer relationship management (CRM). Some companies rely on long-established platforms, while others are adopting… Continue reading → Read the articleno Drug DevelopmentBridging the Feasibility Gap: A Smarter Path to Clinical Trial EnrollmentDespite decades of progress in data access and analytics, the clinical research industry continues to struggle with one seemingly simple challenge: enrolling patients on time. The statistics are stark: nearly… Continue reading → Read the articleno1234›»
